Health
Maker seeking Indian trial of Novavax jab – Eyre Peninsula Tribune
The Serum Institute of India, the world’s biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc’s COVID-19…
The Serum Institute of India, the world’s biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc’s COVID-19 vaccine, which was found to be 89.3 per cent effective in a UK trial.
Serum expected a decision on an Indian trial of Novavax’s vaccine soon, Chief Executive Adar Poonawalla told Reuters on Friday, hours after the US company reported the efficacy data.
“We have already applied to the drug controller’s office for the bridging trial, a few days…
-
Business18 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News18 hours agoYoung voices shape Sunshine Coast’s future
-
General22 hours agoUS stocks sink further as Donald Trump urges Americans to be ‘courageous and patient’
-
General21 hours agoDonald Trump threatens China with additional 50 per cent tariff as trade war threatens to escalate